NBD AI Bulletin,Yifan Pharmaceutical Co., Ltd. (the Company, SZ 002019, closing price: 21.32 yuan) announced on the evening of June 10 that its controlling shareholder Cheng Xianfeng pledged 14 million shares, or 2.69% of his shares in the Company, on June 8, 2020.

According to the 2019 annual report, Yifan Pharmaceutical Co., Ltd. mainly engages in pharmaceutical, raw materials & intermediates, and polymer materials, accounting for 70.61%, 23.82%, 5.56% of its revenue, respectively.

Yifan Pharmaceutical Co., Ltd.'s chairman and general manager is Cheng Xianfeng, male, 52 years old, Chinese national, with a master's degree.

(By Tan Yuhan)

Disclaimer: This article is for informational purposes only and does Not constitute investment advice. Please verify before use. Any action you take upon the information on this website is at your own risk.